Share on StockTwits

Tornier N.V. (NASDAQ:TRNX) VP Ummersen Gordon Van unloaded 1,660 shares of the company’s stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $21.51, for a total value of $35,706.60. Following the transaction, the vice president now directly owns 35,270 shares in the company, valued at approximately $758,658. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

TRNX has been the subject of a number of recent research reports. Analysts at TheStreet upgraded shares of Tornier N.V. from a “sell” rating to a “hold” rating in a research note on Friday. Separately, analysts at Barclays raised their price target on shares of Tornier N.V. from $23.00 to $26.00 in a research note on Thursday. They now have an “overweight” rating on the stock. Finally, analysts at Summer Street upgraded shares of Tornier N.V. from a “sell” rating to a “neutral” rating in a research note on Wednesday, May 7th. They now have a $18.00 price target on the stock, up previously from $16.00. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $20.29.

Shares of Tornier N.V. (NASDAQ:TRNX) opened at 22.40 on Friday. Tornier N.V. has a 52 week low of $15.17 and a 52 week high of $22.45. The stock has a 50-day moving average of $19.98 and a 200-day moving average of $19.23. The company’s market cap is $1.088 billion.

Tornier N.V. (NASDAQ:TRNX) last posted its quarterly earnings results on Tuesday, May 6th. The company reported ($0.11) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.14) by $0.03. The company had revenue of $89.00 million for the quarter, compared to the consensus estimate of $80.41 million. During the same quarter last year, the company posted ($0.17) earnings per share. Tornier N.V.’s revenue was up 7.6% compared to the same quarter last year. Analysts expect that Tornier N.V. will post $-0.45 EPS for the current fiscal year.

Tornier N.V. (NASDAQ:TRNX) is a global medical device company focused on surgeons that treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.